Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 36338D108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Emerald Bioventures, LLC
13D/A
|
30.2% |
5/29/2026
Event 5/15/2026
|
||
| Emerald Bioventures, LLC | 30.2% | |||
| Timothy Opler | 30.2% | |||
| Parvinder Singh Hyare 13D | 6.7% |
6/11/2026
Event 5/15/2026
|
||
| Chang Nancy T 13D | 5.9% |
4/10/2026
Event 12/30/2024
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Ikarian Capital, LLC
13G/A
|
0% |
8/14/2026
Event 6/30/2026
|
||
| Ikarian Capital, LLC | 0% | |||
| Neil Shahrestani | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 1 | 93.0 | $4.00 |
| 2024 Q2 | 1 | 52.1 k | $7.13 k |
| 2024 Q1 | 41 | 9.79 M | $1.37 M |
| 2023 Q4 | 41 | 12.9 M | $1.88 M |
| 2023 Q3 | 41 | 8.77 M | $1.53 M |
| 2023 Q2 | 63 | 18.5 M | $57.8 M |
| 2023 Q1 | 46 | 18.7 M | $54.4 M |
| 2022 Q4 | 37 | 12.0 M | $17.9 M |
| 2022 Q3 | 36 | 10.4 M | $18.1 M |
| 2022 Q2 | 45 | 10.5 M | $13.7 M |
| 2022 Q1 | 56 | 11.3 M | $26.9 M |
| 2021 Q4 | 56 | 11.2 M | $51.3 M |
| 2021 Q3 | 41 | 20.0 M | $162 M |
| 2021 Q2 | 49 | 20.8 M | $204 M |
| 2021 Q1 | 56 | 19.4 M | $171 M |
| 2020 Q4 | 52 | 19.3 M | $197 M |
| 2020 Q3 | 45 | 18.8 M | $170 M |
| 2020 Q2 | 42 | 18.7 M | $134 M |
| 2020 Q1 | 36 | 16.9 M | $160 M |
| 2019 Q4 | 34 | 17.0 M | $224 M |